0001415889-24-027545.txt : 20241122 0001415889-24-027545.hdr.sgml : 20241122 20241122164752 ACCESSION NUMBER: 0001415889-24-027545 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241120 FILED AS OF DATE: 20241122 DATE AS OF CHANGE: 20241122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: COATS LONNEL CENTRAL INDEX KEY: 0001612528 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37359 FILM NUMBER: 241490512 MAIL ADDRESS: STREET 1: 8800 TECHNOLOGY FOREST PLACE CITY: THE WOODLANDS STATE: TX ZIP: 77381 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Blueprint Medicines Corp CENTRAL INDEX KEY: 0001597264 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-374-7580 MAIL ADDRESS: STREET 1: 45 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4-11222024_091148.xml X0508 4 2024-11-20 0001597264 Blueprint Medicines Corp BPMC 0001612528 COATS LONNEL C/O BLUEPRINT MEDICINES CORPORATION 45 SIDNEY STREET CAMBRIDGE MA 02139 true false false false 1 Common Stock 2024-11-20 4 M 0 7500 69.79 A 20754 D Common Stock 2024-11-20 4 M 0 1312 76.24 A 22066 D Common Stock 2024-11-20 4 S 0 4500 93.15 D 17566 D Common Stock 2024-11-20 4 S 0 5287 94.24 D 12279 D Common Stock 2024-11-20 4 S 0 213 94.99 D 12066 D Common Stock 2024-11-21 4 S 0 9824 94.87 D 2242 D Stock Option (Right to Buy) 69.79 2024-11-20 4 M 0 7500 0 D 2028-06-21 Common Stock 7500 0 D Stock Option (Right to Buy) 76.24 2024-11-20 4 M 0 1312 0 D 2030-06-24 Common Stock 1312 3188 D Effected pursuant to a trading plan adopted on August 21, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported is an average price. The shares were sold in multiple transactions ranging from $92.71 to $93.64. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2). The price reported is an average price. The shares were sold in multiple transactions ranging from $93.74 to $94.67. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3). The price reported is an average price. The shares were sold in multiple transactions ranging from $94.74 to $95.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4). This option was granted on June 21, 2018 and is fully vested as of the transaction date. This option was granted on June 24, 2020 and is fully vested as of the transaction date. /s/ Melissa Masse, Attorney-in-Fact 2024-11-22